Hideaki Kinugasa1,2, Kazuhiro Nouso1,3, Soichiro Ako1, Chihiro Dohi1, Hiroshi Matsushita1, Kazuyuki Matsumoto1, Hironari Kato1, Hiroyuki Okada1. 1. a Department of Gastroenterology and Hepatology , Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences , Okayama , Japan. 2. b Department of Gastroenterology and Hepatology , Hiroshima City Hiroshima Citizens Hospital , Hiroshima , Japan. 3. c Department of Gastroenterology , Okayama City Hospital , 3-20-1 Kitanagase-omotemachi, Kita-ku, Okayama , Japan.
Abstract
INTRODUCTION: Tissue sampling of gallbladder cancer (GBCa) is challenging because of the anatomy of the gallbladder. The aim of this study is to investigate the possibility of diagnosing GBCa patients by performing a liquid biopsy of bile in addition to current diagnostic methods. METHODS: Thirty patients with GBCa were enrolled in this study. Cytological examination was performed in all patients. Using next generation sequencing (NGS), DNA isolated from the bile and tumor tissue was analyzed for mutations in 49 oncogenes. We also compared these mutations with cytology results. RESULTS: 57.1% of DNA samples from tumor tissue were positive for a mutation. In these patients, 87.5% of the bile circulating tumor DNA (ctDNA) samples had the same mutation. The concordance rate between bile ctDNA and tissue DNA samples was 85.7%, and the mutation frequencies detected in ctDNA were approximately half of what was detected in tumor tissue DNA. On the other hand, the sensitivity of the cytological and bile ctDNA analyses was 45.8% and 58.3%, respectively. The concordance rate between cytology and bile ctDNA analyses was 87.5%. CONCLUSIONS: Mutated tumor DNA could be detected in bile by NGS. Liquid biopsy of bile might help us to diagnose GBCa because of higher sensitivity and positive predict value compared to cytology with ERCP.
INTRODUCTION: Tissue sampling of gallbladder cancer (GBCa) is challenging because of the anatomy of the gallbladder. The aim of this study is to investigate the possibility of diagnosing GBCa patients by performing a liquid biopsy of bile in addition to current diagnostic methods. METHODS: Thirty patients with GBCa were enrolled in this study. Cytological examination was performed in all patients. Using next generation sequencing (NGS), DNA isolated from the bile and tumor tissue was analyzed for mutations in 49 oncogenes. We also compared these mutations with cytology results. RESULTS: 57.1% of DNA samples from tumor tissue were positive for a mutation. In these patients, 87.5% of the bile circulating tumor DNA (ctDNA) samples had the same mutation. The concordance rate between bile ctDNA and tissue DNA samples was 85.7%, and the mutation frequencies detected in ctDNA were approximately half of what was detected in tumor tissue DNA. On the other hand, the sensitivity of the cytological and bile ctDNA analyses was 45.8% and 58.3%, respectively. The concordance rate between cytology and bile ctDNA analyses was 87.5%. CONCLUSIONS: Mutated tumor DNA could be detected in bile by NGS. Liquid biopsy of bile might help us to diagnose GBCa because of higher sensitivity and positive predict value compared to cytology with ERCP.
Authors: T Itoi; Y Shinohara; K Takeda; K Takei; H Ohno; K Ohyashiki; N Yahata; Y Ebihara; T Saito Journal: Gastrointest Endosc Date: 2000-09 Impact factor: 9.427
Authors: Yuchen Jiao; Timothy M Pawlik; Robert A Anders; Florin M Selaru; Mirte M Streppel; Donald J Lucas; Noushin Niknafs; Violeta Beleva Guthrie; Anirban Maitra; Pedram Argani; G Johan A Offerhaus; Juan Carlos Roa; Lewis R Roberts; Gregory J Gores; Irinel Popescu; Sorin T Alexandrescu; Simona Dima; Matteo Fassan; Michele Simbolo; Andrea Mafficini; Paola Capelli; Rita T Lawlor; Andrea Ruzzenente; Alfredo Guglielmi; Giampaolo Tortora; Filippo de Braud; Aldo Scarpa; William Jarnagin; David Klimstra; Rachel Karchin; Victor E Velculescu; Ralph H Hruban; Bert Vogelstein; Kenneth W Kinzler; Nickolas Papadopoulos; Laura D Wood Journal: Nat Genet Date: 2013-11-03 Impact factor: 38.330
Authors: Marco Calandri; Giulia Siravegna; Andrea Veltri; Bruno C Odisio; Steven M Yevich; Giuseppe Stranieri; Carlo Gazzera; Scott Kopetz; Paolo Fonio; Sanjay Gupta; Alberto Bardelli Journal: Eur Radiol Date: 2020-03-19 Impact factor: 5.315
Authors: Maria Arechederra; María Rullán; Irene Amat; Daniel Oyon; Lucia Zabalza; Maria Elizalde; M Ujue Latasa; Maria R Mercado; David Ruiz-Clavijo; Cristina Saldaña; Ignacio Fernández-Urién; Juan Carrascosa; Vanesa Jusué; David Guerrero-Setas; Cruz Zazpe; Iranzu González-Borja; Bruno Sangro; Jose M Herranz; Ana Purroy; Isabel Gil; Leonard J Nelson; Juan J Vila; Marcin Krawczyk; Krzysztof Zieniewicz; Waldemar Patkowski; Piotr Milkiewicz; Francisco Javier Cubero; Gorka Alkorta-Aranburu; Maite G Fernandez-Barrena; Jesus M Urman; Carmen Berasain; Matias A Avila Journal: Gut Date: 2021-07-20 Impact factor: 31.793